Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
09/2000
09/21/2000WO2000055350A1 Human cancer associated gene sequences and polypeptides
09/21/2000WO2000055332A2 Human regulators of intracellular phosphorylation
09/21/2000WO2000055320A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000WO2000055201A1 49 human secreted proteins
09/21/2000WO2000055200A1 50 human secreted proteins
09/21/2000WO2000055199A1 47 human secreted proteins
09/21/2000WO2000055191A2 Recombinant haemophilus influenzae adhesin proteins
09/21/2000WO2000055180A2 Human lung cancer associated gene sequences and polypeptides
09/21/2000WO2000055177A2 49 human secreted proteins
09/21/2000WO2000055174A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000WO2000055173A1 Human breast and ovarian cancer associated gene sequences and polypeptides
09/21/2000WO2000055159A2 Substituted aza-oxindole derivatives
09/21/2000WO2000055155A2 Heterocyclic compounds as adenosine deaminase inhibitors
09/21/2000WO2000055154A1 Modified amino-acid amides as cgrp antagonists
09/21/2000WO2000055137A1 Compounds and methods for modulation of estrogen receptors
09/21/2000WO2000055126A2 N-cyanomethylamides as protease inhibitors
09/21/2000WO2000055125A2 N-cyanomethyl amides as protease inhibitors
09/21/2000WO2000055114A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000WO2000054813A2 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
09/21/2000WO2000054810A1 Combination therapy for treating glaucoma
09/21/2000WO2000054801A1 Compositions and methods of use of ldl-like receptor ligands for the treatment of cancer and angiogenic-based disease
09/21/2000WO2000054796A1 Novel antiangiogenic peptides
09/21/2000WO2000054794A1 Wafer delivery system
09/21/2000WO2000054779A1 OCULAR THERAPY IN KERATOCONJUCTIVITIS SICCA USING TOPICALLY APPLIED ANDROGENS OR TGF-$g(b)
09/21/2000WO2000054770A1 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
09/21/2000WO2000054762A2 Use of cross linked polysaccharides for the inhibition of angiogenesis
09/21/2000WO2000054757A2 Use of pirenoxine for the protection of corneal tissues in photokeratectomy
09/21/2000WO2000039077A3 Thyroid receptor ligands
09/21/2000WO2000020039A9 Methods and adjuvants for stimulating mucosal immunity
09/21/2000WO2000018407A9 Methods for preventing/treating damage to sensory hair cells and cochlear neurons
09/21/2000WO2000015792A3 Promotion or inhibition of angiogenesis and cardiovascularization
09/21/2000CA2368242A1 Combination therapy for treating glaucoma
09/21/2000CA2368148A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368122A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368068A1 27 human secreted proteins
09/21/2000CA2367895A1 Compounds and methods for modulation of estrogen receptors
09/21/2000CA2367643A1 Ocular therapy in keratoconjuctivitis sicca using topically applied androgens or tgf-.beta.
09/21/2000CA2367611A1 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
09/21/2000CA2367375A1 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
09/21/2000CA2367340A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000CA2367247A1 Compositions and methods of use of ldl-like receptor ligands for the treatment of cancer and angiogenic-based disease
09/21/2000CA2367213A1 Novel antiangiogenic peptides
09/21/2000CA2366195A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000CA2366174A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000CA2366130A1 Human cancer associated gene sequences and polypeptides
09/21/2000CA2365767A1 Angiogenesis inhibition
09/21/2000CA2364739A1 Regulators of intracellular phosphorylation
09/21/2000CA2364667A1 Recombinant haemophilus influenzae adhesin proteins
09/21/2000CA2364637A1 50 human secreted proteins
09/21/2000CA2364635A1 47 human secreted proteins
09/21/2000CA2364629A1 Human lung cancer associated gene sequences and polypeptides
09/21/2000CA2364590A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000CA2363022A1 49 human secreted proteins
09/21/2000CA2361939A1 Modified amino acid amides, pharmaceutical compositions containing these compounds and processes for preparing them
09/21/2000CA2361277A1 49 human secreted proteins
09/20/2000EP1036168A1 Purification and microsequencing of hyaluronidase isozymes
09/20/2000EP1036065A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors
09/20/2000EP1035869A1 Chemically and thermally stable norastemizole formulations
09/20/2000EP1035848A1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels
09/20/2000EP1035824A1 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
09/20/2000CN1267296A Barbituric acid derivs with antimetastatic and antitumor activity
09/20/2000CN1266679A Nanoemulsion based on ethoxylated fatly ether or ethoxylated fatty ester, and use thereof
09/20/2000CN1056608C Pseudodipeptide product having imidazole group and applications
09/20/2000CN1056521C Injection for curing edematous conjunctivitis of piglet
09/20/2000CN1056516C Traditional Chinese medicine preparation for treating cataract, glaucoma and optic actrophy
09/20/2000CN1056511C Process for preparing composition for beauty or pharmaceutical, especially dermotoses and antiallergy by using cucurbin, and use
09/19/2000US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides
09/19/2000US6121326 Antiinflammatory agents; antiallergens; analgesics; antiemetics
09/19/2000US6121300 In a topical cosmetic as skin elasticity improver or wrinkle reducer; compounds such as 3-(2-(3-phenyl-5-isoxazolyl)-2-oxoethyl)-thiazolium; adminsistering to treat cataracts, protein aging and diabetes
09/19/2000US6121280 Azabicyclic rotomase inhibitors
09/19/2000US6121274 Phosphodiesterase inhibitor for treatment of respiratory system disorders
09/19/2000US6121272 Bidentate metalloprotease inhibitors
09/19/2000US6121258 For treatment of arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease
09/19/2000US6121240 Urokinase receptor ligands
09/19/2000US6121231 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury
09/19/2000CA2199294C Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions
09/19/2000CA2184914C Isoxazoline compounds as 5-lipoxygenase inhibitors
09/14/2000WO2000053605A1 Tyrosine kinase inhibitors
09/14/2000WO2000053596A2 Imidazole compounds as histamine h3 ligands
09/14/2000WO2000053562A1 Retinoid antagonists and use thereof
09/14/2000WO2000053236A2 Methods and compositions for targeted drug delivery
09/14/2000WO2000053194A1 Remedies for joint diseases
09/14/2000WO2000053177A1 Liposome preparations
09/14/2000WO2000053157A1 Improved powdery pharmaceutical compositions for inhalation
09/14/2000WO2000037109A3 Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions
09/14/2000WO1999063999A8 H1-histamine receptor antagonists
09/14/2000DE19911039A1 Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Modified amino acid amides, pharmaceutical compositions containing them and methods for their preparation
09/14/2000CA2366644A1 Tyrosine kinase inhibitors
09/14/2000CA2365354A1 Methods and compositions for targeted drug delivery
09/14/2000CA2364257A1 Liposome preparations
09/14/2000CA2362319A1 Imidazole compounds as histamine h3 ligands
09/14/2000CA2361849A1 Promotion or inhibition of angiogenesis and cardiovascularization
09/13/2000EP1035115A1 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists
09/13/2000EP1034793A1 Preventives/remedies for glaucoma
09/13/2000EP1034164A1 Substituted beta-alanine derivatives as cell adhesion inhibitors
09/13/2000CN1266434A 1,2,4-triazolo [4,3-B] pyrido [3,2-D] pyridazine derivatives and pharmaceutical compositions containing them
09/13/2000CN1266431A Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
09/13/2000CN1266369A Dexamethasone gel
09/13/2000CN1266368A Heterocyclic vinylethers against neurological disorders
09/13/2000CN1265898A External medicine for treating tympanitis
1 ... 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 ... 531